Transcatheter coil occlusion of perimembranous ventricular septal defects

Nogi, Shunji; Haneda, Noriyuki; Tomita, Hideshi

doi:10.1002/ccd.21703

Cited by 13 publications

(10 citation statements)

References 55 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Afterwards, other cardiologists followed his lead and used Rashkind’s double-disc patent ductus arteriosus (PDA) umbrella, Rashkind’s ASD double-umbrella, and clamshell devices for transcatheter occlusion of VSDs 21 – 26 . Subsequently, other devices were used to percutaneously occlude the VSDs: buttoned device (Custom Medical Devices, Amarillo, TX, USA) 27 , 28 , CardioSEAL and STARFlex devices (Nitinol Medical Technologies, Inc., Boston, MA, USA) 29 , Nit-Occlud device (pfm - Produkte für die Medizin AG, Köln, Germany) 30 – 33 , Amplatzer Muscular VSD Occluder device (St. Jude Medical, Inc., St. Paul, MN, USA) 34 – 39 , detachable steel coils (Cook, Bloomington, IN, USA) 40 , Gianturco coils (Cook) 41 , flipper, 0.052ʺ Gianturco, or 0.035ʺ platinum coils (Cook) 42 , wireless devices such as detachable balloon and transcatheter patch (Custom Medical Devices) 43 , Amplatzer Duct Occluder (St. Jude Medical, Inc.) 44 , Shanghai symmetrical perimembranous VSD occluder (Shape Memory Alloy Ltd., Shanghai, China) 45 , Amplatzer Duct Occluder II (St. Jude Medical, Inc.) 46 – 56 , Cera devices (Lifetech Scientific Co. Ltd., Shenzhen, China) 57 , and perhaps other devices (not known to the authors).…”

Section: Ventricular Septal Defectsmentioning

confidence: 99%

“…Although CardioSEAL Septal Occlusion System with QwikLoad and the STARFlex Septal Occlusion System have received FDA approval in the past, they are not widely used at present. Free and detachable Gianturco coils 41 , 42 , Nit-Occlud device 30 – 33 , 75 , Amplatzer Duct Occluder 44 , and Amplatzer Duct Occluder II 46 – 56 are also being used on an off-label basis. Discussion of devices used on an off-label basis will not be included in this review; the interested reader may review the respective publications 30 – 33 , 41 , 42 , 44 , 46 – 56 , 75 .…”

Section: Ventricular Septal Defectsmentioning

confidence: 99%

See 1 more Smart Citation

Recent advances in managing septal defects: ventricular septal defects and atrioventricular septal defects

Rao

Harris

2018

F1000Res

View full text Add to dashboard Cite

This review discusses the management of ventricular septal defects (VSDs) and atrioventricular septal defects (AVSDs). There are several types of VSDs: perimembranous, supracristal, atrioventricular septal, and muscular. The indications for closure are moderate to large VSDs with enlarged left atrium and left ventricle or elevated pulmonary artery pressure (or both) and a pulmonary-to-systemic flow ratio greater than 2:1. Surgical closure is recommended for large perimembranous VSDs, supracristal VSDs, and VSDs with aortic valve prolapse. Large muscular VSDs may be closed by percutaneous techniques. A large number of devices have been used in the past for VSD occlusion, but currently Amplatzer Muscular VSD Occluder is the only device approved by the US Food and Drug Administration for clinical use. A hybrid approach may be used for large muscular VSDs in small babies. Timely intervention to prevent pulmonary vascular obstructive disease (PVOD) is germane in the management of these babies. There are several types of AVSDs: partial, transitional, intermediate, and complete. Complete AVSDs are also classified as balanced and unbalanced. All intermediate and complete balanced AVSDs require surgical correction, and early repair is needed to prevent the onset of PVOD. Surgical correction with closure of atrial septal defect and VSD, along with repair and reconstruction of atrioventricular valves, is recommended. Palliative pulmonary artery banding may be considered in babies weighing less than 5 kg and those with significant co-morbidities. The management of unbalanced AVSDs is more complex, and staged single-ventricle palliation is the common management strategy. However, recent data suggest that achieving two-ventricle repair may be a better option in patients with suitable anatomy, particularly in patients in whom outcomes of single-ventricle palliation are less than optimal. The majority of treatment modes in the management of VSDs and AVSDs are safe and effective and prevent the development of PVOD and cardiac dysfunction.

show abstract

Section: Ventricular Septal Defectsmentioning

confidence: 99%

Section: Ventricular Septal Defectsmentioning

confidence: 99%

Recent advances in managing septal defects: ventricular septal defects and atrioventricular septal defects

Rao

Harris

2018

F1000Res

View full text Add to dashboard Cite

show abstract

“…[21–26] Some authors reported ASD and VSD closures as the former procedure of a combined intervention, with an embolization of a PDA or a pulmonary balloon valvuloplasty performed after those procedures. [182728] In our study, coil embolization of ductus in four and coarctation balloon angioplasty in one patient were successfully performed as second procedures of combined interventions after percutanous VSD closure as the first procedure.…”

Section: Discussionmentioning

confidence: 99%

Multiple transcatheter interventions in the same session in congenital cardiopathies

Sarıtaş

Erdem²,

Akdeni̇z³

et al. 2010

Journal of Cardiovascular Disease Research

View full text Add to dashboard Cite

Background:To investigate the methods of percutaneous transcatheter interventions for combined congenital heart disease and to evaluate its efficacy in children.Materials and Methods:Thirty cases (ages 3 days-13.5 years, body weight 3-35 kg) that underwent two multiple transcatheter interventions for combined or solitary congenital heart disease were retrospectively analyzed and presented.Results:A total of 61 transcatheter interventions were performed in 30 patients as combined procedures. In 29 patients, two different procedures were combined in the same session, in remaining one patient, combination of three interventions were performed in the same catheter session. Interventions performed in combined procedures were as follows: Coarctation balloon angioplasty in 12 cases, pulmonary balloon valvuloplasty in 10, PDA coil embolization in 10, aortic balloon valvuloplasty in 8, VSD closure in 5, ASD closure in 4, ductal stent implantation in 4, palliative pulmonary balloon valvuloplasty in 3, recanalization and angioplasty of the systemic-pulmonary shunt in 2, balloon atrial septostomy in one, aortic coarctation stent implantation in one, coil embolization of a pulmonary lobar sequestration in one and pulmonary valve perforation plus pulmonary balloon valvuloplasty in one were performed as first or second procedure. There was no mortality or major morbidity in relation to combined procedures.Conclusion:Multiple transcatheter interventions in the same session are feasible, safe and effective with satisfactory good results. Second intervention may be performed as complementary procedure or independently to the first intervention.

show abstract

“…[1][2][3] It is categorized according to the location of the principal lesion in the interventricular septum. 5 Surgical closure of VSD has been the treatment of choice in the majority of cases. 4 Subjects with untreated VSD carry a high risk of developing complications such as infective endocarditis, which has a reported incidence of 14.5 per 10 000 patient-years.…”

Section: Introductionmentioning

confidence: 99%

“…Three main types of VSD are perimembranous, muscular, and supracristal, with perimembranous VSD being the most common type. 5,6 However, postsurgical residual VSD has been reported in 9-36% of all VSDs undergoing surgical repair. 5 Surgical closure of VSD has been the treatment of choice in the majority of cases.…”

Section: Introductionmentioning

confidence: 99%

Clinical Experience of Transcatheter Closure for Residual Ventricular Septal Defect in Pediatric Patients

Zhou

et al. 2016

Congenital Heart Disease

View full text Add to dashboard Cite

show abstract

Transcatheter coil occlusion of perimembranous ventricular septal defects

Abstract: Transcatheter coil occlusion of a VSD can be performed reliably and safely by selecting appropriate embolic coils. Small defects (<2.5 mm) can be closed with a flipper coil, but defects >or=2.5 mm require a 0.052'' coil.

Cited by 13 publications

References 55 publications

Recent advances in managing septal defects: ventricular septal defects and atrioventricular septal defects

Recent advances in managing septal defects: ventricular septal defects and atrioventricular septal defects

Multiple transcatheter interventions in the same session in congenital cardiopathies

Clinical Experience of Transcatheter Closure for Residual Ventricular Septal Defect in Pediatric Patients

Contact Info

Product

Resources

About